Help HRF Change The World

Kicking Cancer’s Ass!

First, do no harm to the patient. Decrease the incidence of primary cancers and the recurrence of previously treated cancers by using an algorithm which monitors circulating cancer stem cells.

  • Educate

  • Advocate

  • Facilitate

Donate Today

Help HRF Change The World

Kicking Cancer’s Ass!

First, do no harm to the patient. Decrease the incidence of primary cancers and the recurrence of previously treated cancers by using an algorithm which monitors circulating cancer stem cells.

  • Educate

  • Advocate

  • Facilitate

Donate Today

Help HRF Change The World

Kicking Cancer’s Ass!

First, do no harm to the patient. Decrease the incidence of primary cancers and the recurrence of previously treated cancers by using an algorithm which monitors circulating cancer stem cells.

  • Educate

  • Advocate

  • Facilitate

Donate Now

Hippocrates at a Glance

The experts at HRF have years of experience successfully preventing cancer and the recurrence of cancer through monitoring circulating cancer stem cells (CSC) detectable in the blood, years prior to any clinical evidence of disease.

​This work was done in a small group of highly motivated patients.

​Research is needed to validate and replicate their initial work on a larger patient population and among patients with different types of cancer.

There is no miracle pill to prevent cancer. The experts at HRF stack methods known to inhibit cancer without side effects.

HRF is applying for a workflow patent that outlines its process for primary and secondary cancer prevention. This will be a step-by-step algorithm for physicians and patients to follow.

Currently, HRF is most interested in studying patients previously treated for cancer and now in remission. The vast majority of cancer patients thought to be cancer-free will have detectable CSC.

Meet Our Team

Our leadership team and board of directors are dedicated to the necessary research that empowers us to educate patients and advocate on their behalf, while facilitating healing and life transformation.

Dr. Michelle Howard
Dr. Michelle HowardCo-Founder, Hippocrates Research Foundation
Read Biography
Dr. Gregory Howard
Dr. Gregory HowardCo-Founder, Hippocrates Research Foundation
Read Biography
Daniel Orrego
Daniel OrregoCo-Founder, Hippocrates Research Foundation
Read Biography
Dr. Garth Nicolson
Dr. Garth NicolsonChairman of the Scientific Advisory Board
Read Biography

Statistics

Statistics don’t lie! ‘Standard of Care’ medicine does not prevent obesity, Type II Diabetes, or cancer.

33%

1 out of 3 women will experience cancer in their lifetime.

50%

1 out of 2 men will experience cancer in their lifetime.

42.4%

The US obesity prevalence was 42.4% in 2018.

10.5%

The US type II diabetes 10.5% in 2018.

35%

The US pre-iabetic prevalence was 35% in 2018.

Type II Diabetes and obesity increase the risk of developing stage zero cancer, plus greatly decrease survivorship among those diagnosed with later-stage cancers.

There are at least 5 companies that offer commercially available liquid biopsies which detect cancer years before conventional screening tests. Why don’t you know about these companies and tests?

When cancer is detected by conventional screening methods you will receive some combination of chemotherapy, radiation therapy, surgery, and immunotherapy. These therapies are expensive, toxic, and potential complications can lead to death.

Please Donate Today

Your generous donation helps the Hippocrates Research Foundation
to make a profoundly positive impact in the countless lives of others.

Donate Today

Your generous donation helps the Hippocrates Research Foundation
to make a profoundly positive impact in the countless lives of others.